Clinical Trials in Austin

Showing 9781-9800 of 15,205 trials

A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers

NCT03892499

To evaluate the effect of itraconazole (a potent cytochrome P450 isoenzyme \[CYP\]3A inhibitor) on the pharmacokinetics (PK) of olinciguat

Healthy

Cyclerion Therapeutics24 participantsStarted May 2019

Austin, Texas, United States

TERMINATEDPhase 2< 1 mile

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT03676231

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the safety, pharmacokinetics, and pharmacodynamics of 12 weeks' administration of SGM-1019 in subjects with fibrosis stage 1-3 (F1-F3) NASH.

Nonalcoholic Steatohepatitis

Second Genome9 participantsStarted Jan 2019

Chandler, Arizona, United States • Tucson, Arizona, United States • Panorama City, California, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

NCT01919697

This is a multi-center, open-label, 52-week safety and tolerability study of plecanatide in patients with Chronic Idiopathic Constipation (CIC).

Chronic Idiopathic Constipation

Bausch Health Americas, Inc.2,370 participantsStarted Aug 2013

Birmingham, Alabama, United States • Dothan, Alabama, United States • Gulf Shores, Alabama, United States +217 more locations

A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

Find Trials by Condition in Austin

Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use

Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

ATHENA: Natural History of Disease Study in Alport Syndrome Patients

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection